Aurinia Pharmaceuticals Inc
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
23.24
-0.27
(-1.148%)
Volume:
2,774,809
52 week range:
9.72 - 24.18
Market Cap:
2.984B
Company Description:
Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company’s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.